Table 1 PFKFB4 expression and clinicopathological characteristics of patients with COAD.
From: Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients
Variables | Case, n | PFKFB4 expression | χ2 | p-value | |
|---|---|---|---|---|---|
Low, n (7) | High, n (72) | ||||
Age, years | |||||
≤ 62 | 40 | 25 (62.50) | 15 (37.50) | 1.9420 | 0.1634 |
> 62 | 39 | 30 (76.92) | 9 (23.08) | ||
Gender | |||||
Male | 36 | 27 (75.00) | 9 (25.00) | 0.9050 | 0.3414 |
Female | 43 | 28 (65.12) | 15 (34.88) | ||
Type | |||||
Others colon | 45 | 36 (88.00) | 9 (20.00) | 5.3260 | 0.0210a |
Sigmoid colon | 34 | 19 (55.88) | 15 (44.12) | ||
Differentiation | |||||
Well + Moderate | 40 | 36 (72.00) | 14 (28.00) | 0.2381 | 0.6256 |
Poor | 27 | 18 (66.67) | 9 (33.33) | ||
NA* | 2 | 1 (50.00) | 1 (50.00) | ||
Tumor size, cm | |||||
≤ 4 | 45 | 32 (71.11) | 13 (28.89) | 0.1765 | 0.6744 |
> 4 | 33 | 22 (66.67) | 11 (33.33) | ||
NA* | 1 | 1 (100.00) | 0 (0.00) | ||
pT stage | |||||
T1 + 2 | 13 | 11 (84.62) | 2 (15.38) | 0.9750 | 0.3234 |
T3 + 4 | 65 | 43 (66.15) | 22 (33.85) | ||
NA* | 1 | 1 (100.00) | 0 (0.00) | ||
pN stage | |||||
N0 | 41 | 38 (74.51) | 13 (25.49) | 1.9270 | 0.1650 |
N1 + 2 | 27 | 16 (59.26) | 11 (40.74) | ||
NA* | 1 | 1 (100.00) | 0 (0.00) | ||
pM stage | |||||
M0 | 76 | 53 (69.74) | 23 (30.26) | > 0.9999b | |
M1 | 3 | 2 (66.67) | 1 (33.33) | ||
Dukes stage | |||||
A + B | 49 | 3 (75.51) | 12 (24.49) | 2.44 | 0.1183 |
C + D | 29 | 17 (58.62) | 12 (41.38) | ||
NA* | 1 | 1 (100.00) | 0 (0.00) | ||
